3. Kim YH, Kang KJ, Kwon JH. 2005; Four cases of hepatic fascioliasis mimicking cholangiocarcinoma. Korean J Hepatol. 11:169–175. DOI:
10.1016/0168-8278(90)90199-2. PMID:
15980676.
4. Kang BK, Jung BK, Lee YS, et al. 2014; A case of
Fasciola hepatica infection mimicking cholangiocarcinoma and ITS-1 sequencing of the worm. Korean J Parasitol. 52:193–196. DOI:
10.3347/kjp.2014.52.2.193. PMID:
24850964. PMCID:
PMC4028458.
5. Ha JS, Choi HJ, Moon JH, et al. 2015; Endoscopic extraction of biliary fascioliasis diagnosed using intraductal ultrasonography in a patient with acute cholangitis. Clin Endosc. 48:579–582. DOI:
10.5946/ce.2015.48.6.579. PMID:
26668810. PMCID:
PMC4676668.
Article
6. Marcos LA, Terashima A, Gotuzzo E. 2008; Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis. 21:523–530. DOI:
10.1097/QCO.0b013e32830f9818. PMID:
18725803.
Article
7. Aksoy DY, Kerimoğlu U, Oto A, et al. 2006; Fasciola hepatica infection: clinical and computerized tomographic findings of ten patients. Turk J Gastroenterol. 17:40–45. PMID:
16830276.
8. Fica A, Dabanch J, Farias C, Castro M, Jercic MI, Weitzel T. 2012; Acute fascioliasis--clinical and epidemiological features of four patients in Chile. Clin Microbiol Infect. 18:91–96. DOI:
10.1111/j.1469-0691.2011.03575.x. PMID:
21668579.
Article
9. Dusak A, Onur MR, Cicek M, Firat U, Ren T, Dogra VS. 2012; Radiological imaging features of fasciola hepatica infection - a pictorial review. J Clin Imaging Sci. 2:2. DOI:
10.4103/2156-7514.92372. PMID:
22347685. PMCID:
PMC3279695.
Article
10. Kaya M, Beştaş R, Cetin S. 2011; Clinical presentation and management of
Fasciola hepatica infection: single-center experience. World J Gastroenterol. 17:4899–4904. DOI:
10.3748/wjg.v17.i44.4899. PMID:
22171131. PMCID:
PMC3235633.
11. Acosta-Ferreira W, Vercelli-Retta J, Falconi LM. 1979;
Fasciola hepatica human infection. Histopathological study of sixteen cases. Virchows Arch A Pathol Anat Histol. 383:319–327. DOI:
10.1007/BF00430249. PMID:
158874.
12. Espinoza JR, Maco V, Marcos L, et al. 2007; Evaluation of Fas2-ELISA for the serological detection of
Fasciola hepatica infection in humans. Am J Trop Med Hyg. 76:977–982. DOI:
10.4269/ajtmh.2007.76.977. PMID:
17488926.
14. Gulsen MT, Savas MC, Koruk M, Kadayifci A, Demirci F. 2006; Fascioliasis: a report of five cases presenting with common bile duct obstruction. Neth J Med. 64:17–19. PMID:
16421437.
15. Patrick DM, Isaac-Renton J. 1992; Praziquantel failure in the treatment of
Fasciola hepatica. Can J Infect Dis. 3:33–36. DOI:
10.1155/1992/864093. PMID:
22451761. PMCID:
PMC3307422.
16. Keiser J, Engels D, Büscher G, Utzinger J. 2005; Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs. 14:1513–1526. DOI:
10.1517/13543784.14.12.1513. PMID:
16307491.
Article
17. Krsak M, Patel NU, Poeschla EM. 2019; Case report: hepatic fascioliasis in a young afghani woman with severe wheezing, high-grade peripheral eosinophilia, and liver lesions: a brief literature review. Am J Trop Med Hyg. 100:588–590. DOI:
10.4269/ajtmh.18-0625. PMID:
30628571. PMCID:
PMC6402889.
Article
18. Sapmaz F, Kalkan IH, Guliter S, Nazlıoğlu A. 2013; A clinical presentation of a very rare infection: parenchymal
Fasciola hepatica. Turkiye Parazitol Derg. 37:305–306. DOI:
10.5152/tpd.2013.2998. PMID:
24412878.